Moderna Therapeutics, a US-based life sciences firm with ties to multiple universities, closes biggest biotech venture capital round in history at $450m.

Medical imaging company Butterfly Network graduates from incubator raising $100m from investors including Stanford University.

Imperial Innovations has a full pot of cash following its IPO successes of Circassia and Abzena.

The cancer immunotherapy startup is rushing past $300m in funding.

Its total funding now stands at nearly $310m.

The Stanford-backed company closes its series C at $100m, with a predicted valuation of $1bn.

The biotechnology company has closed the funding round it started in December 2013.

Already launching in December with one of the largest series A rounds in history, Juno Therapeutics extends the venture round by a further $25m.